Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHDIV.L Regulatory News (HDIV)

  • There is currently no data for HDIV

Update research from QuotedData

17 Mar 2022 12:56

RNS Number : 1635F
Henderson Diversified Income TstPLC
17 March 2022
 

Henderson Diversified Income Trust - Update research from QuotedData

 

17th March 2022

 

Ahead of the curve

 

Henderson Diversified Income (HDIV) is managed with a focus on good quality issuers of debt securities operating in growing industries. Sustainability is an important factor in any assessment of quality. On 25 February 2022, shareholders overwhelmingly approved a new investment objective and policy that seeks to better define and highlight the trust's approach to environmental, social and governance (ESG) issues.

 

Recent market jitters triggered by the war in Ukraine have left HDIV trading on a much wider discount to NAV and higher dividend yield than its long-run averages.

 

Markets were already pricing in a number of interest rate rises this year as central bankers look to choke off inflation. As we explain in this note, the managers have positioned the trust's conservative and quality-focused portfolio in anticipation of a swift end to this process. That could help trigger the next phase of outperformance by the trust, as bond yields compress and their price rises to reflect lower than expected interest rates.

 

Full research:

 

https://quoteddata.com/research/henderson-diversified-income-trust-curve-qd/ 

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note on Henderson Diversified Income Trust Plc and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the FCA. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA123a Kings Road | London SW3 4PLTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUBVURUVUOAAR
Date   Source Headline
8th Sep 20231:53 pmRNSNet Asset Value(s)
7th Sep 20231:06 pmRNSNet Asset Value(s)
5th Sep 202312:04 pmRNSNet Asset Value(s)
4th Sep 20232:53 pmRNSNet Asset Value(s)
1st Sep 20231:56 pmRNSNet Asset Value(s)
31st Aug 202312:42 pmRNSNet Asset Value(s)
30th Aug 202312:15 pmRNSNet Asset Value(s)
29th Aug 20231:45 pmRNSNet Asset Value(s)
25th Aug 202312:27 pmRNSNet Asset Value(s)
24th Aug 20231:11 pmRNSNet Asset Value(s)
23rd Aug 20231:10 pmRNSNet Asset Value(s)
22nd Aug 20231:46 pmRNSDividend Declaration
22nd Aug 202311:56 amRNSNet Asset Value(s)
21st Aug 20233:53 pmRNSMonthly Factsheet as at 31 July 2023
21st Aug 20232:25 pmRNSNet Asset Value(s)
18th Aug 202312:15 pmRNSNet Asset Value(s)
17th Aug 20231:01 pmRNSNet Asset Value(s)
16th Aug 20231:08 pmRNSNet Asset Value(s)
15th Aug 202312:40 pmRNSNet Asset Value(s)
14th Aug 20233:00 pmRNSNet Asset Value(s)
11th Aug 202312:16 pmRNSNet Asset Value(s)
10th Aug 202312:01 pmRNSNet Asset Value(s)
9th Aug 202311:24 amRNSNet Asset Value(s)
8th Aug 202311:48 amRNSNet Asset Value(s)
7th Aug 20231:52 pmRNSNet Asset Value(s)
4th Aug 202312:20 pmRNSNet Asset Value(s)
4th Aug 202310:04 amRNSHolding(s) in Company
3rd Aug 202312:45 pmRNSNet Asset Value(s)
2nd Aug 202312:31 pmRNSNet Asset Value(s)
2nd Aug 20239:57 amRNSDoc re. Annual Financial Report
1st Aug 202312:52 pmRNSNet Asset Value(s)
31st Jul 20232:16 pmRNSNet Asset Value(s)
28th Jul 202312:14 pmRNSNet Asset Value(s)
27th Jul 202312:16 pmRNSNet Asset Value(s)
26th Jul 202311:12 amRNSNet Asset Value(s)
25th Jul 202311:42 amRNSNet Asset Value(s)
25th Jul 20237:00 amRNSAnnual Financial Report
24th Jul 20232:43 pmRNSNet Asset Value(s)
21st Jul 202311:57 amRNSNet Asset Value(s)
21st Jul 202310:51 amRNSMonthly Factsheet as at 30 June 2023
20th Jul 20231:35 pmRNSNet Asset Value(s)
19th Jul 202311:51 amRNSNet Asset Value(s)
18th Jul 202311:48 amRNSNet Asset Value(s)
17th Jul 20232:23 pmRNSNet Asset Value(s)
14th Jul 202312:44 pmRNSNet Asset Value(s)
14th Jul 202310:56 amRNSNet Asset Value(s)
12th Jul 202312:55 pmRNSNet Asset Value(s)
11th Jul 202312:49 pmRNSNet Asset Value(s)
10th Jul 20232:17 pmRNSNet Asset Value(s)
7th Jul 202312:37 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.